Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/13CA78D7AFF20FFB82DA65C72270F721D4725AE614B934E839C52EF176D1642FCA4297D57F67C52E35EEB2D292D23C9Ahttp://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/13CA78D7AFF20FFB82DA65C72270F721D4725AE614B934E839C52EF176D1642FCA4297D57F67C52E35EEB2D292D23C9Ahttp://www.w3.org/2000/01/rdf-schema#comment"MGMT methylation is a prognostic factor in newly diagnosed glioblastoma. In this study we evaluated the rate of change of MGMT methylation during the clinical course of the disease and we found a significant concordance between the first and the second MGMT methylation assessments with MGMT methylation being stable in 75% of the cases"xsd:string
http://purl.uniprot.org/uniprot/#_41B110BE25BE75EE8DE309045C4E186E2F89D6650FDD3F6B5E610E4F37EB4B85BA65EDD2C7ED67A76BA493F121F628BFhttp://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/13CA78D7AFF20FFB82DA65C72270F721D4725AE614B934E839C52EF176D1642FCA4297D57F67C52E35EEB2D292D23C9A
http://purl.uniprot.org/uniprot/B4DEE8http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/13CA78D7AFF20FFB82DA65C72270F721D4725AE614B934E839C52EF176D1642FCA4297D57F67C52E35EEB2D292D23C9A
http://purl.uniprot.org/uniprot/#_B4DEE8-mappedCitation-28275120http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/13CA78D7AFF20FFB82DA65C72270F721D4725AE614B934E839C52EF176D1642FCA4297D57F67C52E35EEB2D292D23C9A